Search Results - "Priemel, P.A."

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Unintended and in situ amorphisation of pharmaceuticals by Priemel, P.A., Grohganz, H., Rades, T.

    Published in Advanced drug delivery reviews (01-05-2016)
    “…Amorphisation of poorly water-soluble drugs is one approach that can be applied to improve their solubility and thus their bioavailability. Amorphisation is a…”
    Get full text
    Journal Article
  2. 2

    Preparation and investigation of P28GST-loaded PLGA microparticles for immunomodulation of experimental colitis by Thi, T.H. Hoang, Priemel, P.A., Karrout, Y., Driss, V., Delbeke, M., Dendooven, A., Flament, M.P., Capron, M., Siepmann, J.

    Published in International journal of pharmaceutics (25-11-2017)
    “…[Display omitted] The aim of this work was to prepare and characterize (in vitro and in vivo) PLGA-based microparticles loaded with an enzymatic protein…”
    Get full text
    Journal Article
  3. 3

    The impact of surface- and nano-crystallisation on the detected amorphous content and the dissolution behaviour of amorphous indomethacin by Priemel, P.A., Grohganz, H., Gordon, K.C., Rades, T., Strachan, C.J.

    “…Differences in quantified amorphous content are due to surface- and nano-crystallisation of the samples which are not reflected by the quantification models…”
    Get full text
    Journal Article